Personalized Medicine Decision-Making in a Virtual Clinical Setting
- How people respond to drugs depends in part on their genes. For some drugs, doctors can use an individuals genetic background to help in dosing the drug. Researchers want to know how doctors incorporate personalized or genomic medicine into clinical practice.
- To study how physicians make personalized treatment decisions
- Healthy adult primary care physicians who are internal (or family) medicine residents.
- Participants will complete a screening form.
- Participants will manage a mock patient in an immersive virtual environment. They will get Emergency Department discharge data about a 27-year-old virtual patient.
- Participants will put on a helmet. This will have a head-mounted display showing a virtual reality environment.
- The environment will contain an exam room and a virtual patient to interact with.
- Participation will last for about 60 minutes. The virtual patient interaction will be audio taped.
Deep Vein Thrombosis
|Study Design:||Time Perspective: Cross-Sectional|
|Official Title:||Medical Decision-Making in a Virtual Clinical Setting|
- To examine how physicians make decisions about pharmacogenetic testing related to anticoagulant (warfarin) response for patients. [ Time Frame: Ongoing ] [ Designated as safety issue: No ]
|Study Start Date:||March 2014|
|Estimated Study Completion Date:||July 2016|
|Estimated Primary Completion Date:||July 2016 (Final data collection date for primary outcome measure)|
Please refer to this study by its ClinicalTrials.gov identifier: NCT02108041
|Contact: Vence L Bonham, J.D.||(301) email@example.com|
|United States, Maryland|
|Johns Hopkins School of Medicine||Recruiting|
|Baltimore, Maryland, United States, 21205|
|United States, Massachusetts|
|Harvard School of Public Health||Recruiting|
|Boston, Massachusetts, United States, 02115|
|United States, Michigan|
|University of Michigan, School of Public Health||Recruiting|
|Ann Arbor, Michigan, United States, 48109-2029|
|United States, New York|
|New York, New York, United States, 10032-3784|
|Principal Investigator:||Vence L Bonham, J.D.||National Human Genome Research Institute (NHGRI)|